Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders – Business Wire (press release)
Business Wire (press release) |
Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders
Business Wire (press release) EDINBURGH, Scotland–(BUSINESS WIRE)–Synpromics Ltd, the leader in gene control, announces a collaboration with UCL Great Ormond Street Institute of Child Health, to develop novel gene therapies for pathologies affecting the haematopoietic system … |
